Psychedelic drugs are gathering support as a bona fide treatment for mental health problems, one of the most pressing and costly crises facing the modern world.
As a company, we are exploring every opportunity on offer in this new area of research, forming partnerships with pioneering companies.
Our current focus is on the psilocybin space, looking at methods of improving delivery systems for the compound, and creating strong intellectual property.
The company explores many other medical areas including weight loss, skin care and heart disease.